Combined Treatment of Resistant Hypertension and Atrial Fibrillation

NCT01117025 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Meshalkin Research Institute of Pathology of Circulation